Calamos Advisors LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$5,151,585
+20.0%
61,343
+8.2%
0.02%
+19.0%
Q1 2023$4,294,195
+15.5%
56,704
-5.9%
0.02%
+23.5%
Q4 2022$3,717,519
+35.5%
60,232
-8.4%
0.02%
+30.8%
Q3 2022$2,744,000
-29.8%
65,730
-44.4%
0.01%
-23.5%
Q3 2021$3,910,000118,1410.02%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sandhill Capital Partners LLC 1,805,518$34,594,0002.69%
Millrace Asset Group, Inc. 83,723$1,604,0000.94%
Bullseye Asset Management LLC 117,031$2,218,0000.88%
Taylor Wealth Management Partners 72,782$1,395,0000.49%
MOODY ALDRICH PARTNERS LLC 166,078$3,182,0000.44%
HARBOURVEST PARTNERS LLC 116,123$2,225,0000.28%
NEXT CENTURY GROWTH INVESTORS LLC 161,819$3,100,0000.28%
EMERALD MUTUAL FUND ADVISERS TRUST 300,492$5,757,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 82,255$1,576,0000.18%
EMERALD ADVISERS, LLC 244,816$4,691,0000.17%
View complete list of TRANSMEDICS GROUP INC shareholders